Erdafitinib
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Erdafitinib (JNJ-42756493), a quinoxaline derivative, targets FGFR1/2/3/4. Target:... more
Product information "Erdafitinib"
Description: Erdafitinib (JNJ-42756493), a quinoxaline derivative, targets FGFR1/2/3/4. Target: Apoptosis, FGFR. Smiles: COc1cc(OC)cc(c1)N(CCNC(C)C)c1ccc2ncc(nc2c1)-c1cnn(C)c1. References: Verstraete M, et al. In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer. BMC Cancer. 2015 Dec 16,15:946.
| Keywords: | JNJ-42756493 |
| Supplier: | TargetMol |
| Supplier-Nr: | T3726 |
Properties
| Application: | Targets fibroblast growth factor receptor 3 [EC:2.7.10.1] (FGFR3, CD333) |
| MW: | 446.54 D |
| Formula: | C25H30N6O2 |
Database Information
| CAS : | 1346242-81-6| Matching products |
| KEGG ID : | K05093 | Matching products |
Handling & Safety
| Storage: | +4°C |
| Shipping: | +4°C (International: +4°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H302, H317, H318, H361, H372 |
| P Phrases: | P201, P202, P260, P261, P264, P270, P272, P280, P314, P321, P330, P301+P310, P302+P352, P305+P351+P338, P308+P313, P333+P313, P362+P364, P405, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed